# Autotacbio

**Canonical:** https://apis.io/providers/autotacbio/  
**Website:** http://www.autotacbio.com  
**APIs profiled:** 0

Autotacbio (AUTOTAC Bio) is a biotechnology company developing first‑in‑class therapeutics based on its proprietary AUTOTAC (Autophagy‑Targeting Chimera) platform. The company focuses on targeted protein degradation to treat neurodegenerative diseases, cancer, metabolic disorders, and other conditions by directing disease‑causing proteins to autophagy for lysosomal clearance. It operates from Seoul, Korea, and aims to become a global pharmaceutical leader.

## Kin Score — 3.1 / 100 (minimal)

Scored 2026-10-17 under rubric 0.24.0. Trend: flat (+0.1 from 3.0).

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 5.9 (matched via fallback).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Autotacbio Domain Security** — no transport/DNS hardening detected

## Tags

Biotechnology, Protein Degradation, Therapeutics, South Korea, AUTOTAC

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/autotacbio/). Scores are computed from the provider's own public artifacts under a published rubric.